Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Daniel E. Freedberg(NewYork–Presbyterian Hospital), Donald W. Landry, Kevin J. Tracey(Northwell Health), Zhezhen Jin, David A. Tuveson(Cold Spring Harbor Laboratory), Julian A. Abrams(Columbia University Irving Medical Center), Aakriti Gupta, Max R. O’Donnell(Columbia University Irving Medical Center), Magdalena E. Sobieszczyk(Columbia University Irving Medical Center), Timothy C. Wang(Columbia University Irving Medical Center), Jianhua Li(Jilin University), William C. Turner, Michael V. Callahan(Massachusetts General Hospital), David Markowitz, Joseph Conigliaro(Northwell Health)
Cited by 261
Related Papers
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
|The Journal of Experimental Medicine|2017|2.4k
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
|The Lancet|2020|2.3k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Analysis of lung tumor initiation and progression using conditional expression of oncogenic <i>K-ras</i>
|Genes & Development|2001|2k